Jordan Park
Healthcare & Biotech Analyst
Articles 769
CES 2026 ‘Worst in Show’ Highlights AI Overreach and Privacy Concerns
Annual awards spotlight tech products criticized for privacy risks, environmental impacts, and questionable AI applications
The 2026 Consumer Electronics Show (CES) showcased advancements in artificial intelligence, but also became the stage for an infamous annual contest i...
CrowdStrike Enhances Identity Security Portfolio with SGNL Acquisition
Strategic Purchase Aims to Address Security Vulnerabilities in AI-Driven Hybrid Environments
CrowdStrike Holdings, Inc. has announced its plan to acquire SGNL, a move intended to fortify its identity protection capabilities amidst evolving cyb...
Hims & Hers: From GLP-1 Noise to Global Platform Growth - A Tactical Long
Buy the dip on durable subscription economics and international expansion; manage the GLP-1 headline risk
Hims & Hers (HIMS) has transitioned from a startup telehealth play into a profitable, cash-generative consumer health platform. Recent quarters show s...
Mark Cuban Critiques U.S. Healthcare System for Prioritizing Executive Profits Over Patient Care
High Deductibles Shift Costs to Patients While Boosting CEO Earnings, Cuban Argues
Billionaire entrepreneur Mark Cuban has intensified his critique of the U.S. healthcare system, focusing on the impact of high-deductible insurance pl...
Commercial Metals Shares Slip Despite Strong Q1 Earnings Beat
Robust Steel Margins and Construction Demand Offset by Anticipated Headwinds
Commercial Metals Co. exceeded first-quarter earnings expectations owing to improved steel margins and robust construction activity. However, the comp...
Navigating Eco-Conscious Choices in Toilet Paper Consumption
Understanding Sustainable Practices and Materials in Bath Tissue Production
Toilet paper consumption significantly impacts the environment, with traditional production relying on tree fibers and energy-intensive processes that...
Alumis Inc. Expands Capital Raise in Support of Immune Disease Therapeutic Programs
Biotech shares see modest premarket gains as analysts increase price targets amid $300 million equity offering
Alumis Inc. has initiated a significant equity offering, aiming to generate approximately $300 million to support its pipeline of precision medicines ...
Phathom Pharmaceuticals Updates Q4 and Full-Year 2025 Financial Outlook Amid Ongoing Product Progress
Vonoprazan Prescription Growth and Phase 2 Trial Initiation Mark Key Developments as Company Plans Further Capital Raise
Phathom Pharmaceuticals Inc. recently released preliminary financial data for the fourth quarter and full year 2025, signaling slight revenue growth a...
JPMorgan's Q4 Earnings Preview: Dividend Strategy to Generate Steady Income
Analyzing how investors might leverage JPMorgan's dividend yield for monthly income ahead of upcoming earnings release
JPMorgan Chase & Co. is set to announce its fourth quarter earnings before market open on January 13, 2025, with expectations for higher earnings and ...
Utility Stocks with Strong Dividend Yields Draw Expert Analyst Opinions
Insight from top analysts on Eversource Energy, Avista Corp, and AES Corp dividend prospects amid market volatility
Investors often seek stability and yield in turbulent markets, positioning utility stocks with substantial dividend payouts as attractive options. Lea...